MDCX vs GTBP

Comparison between MDCorp (MDCX, Company) and GT Biopharma Inc (GTBP, Company).

Both MDCX and GTBP are from the Healthcare sector.

5-Year PerformanceMDCX has outperformed GTBP, delivering a return of +31.9% compared to -75.1%

MDCX vs GTBP - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	MDCX(COMPANY)	GTBP(COMPANY)
Market Cap	$18M	$18M
Max Drawdown	96.47%	99.99%
Sharpe Ratio	-0.69	-0.73
5Y Beta	1.00	1.24
Industry	Drug Manufacturers - General	Biotechnology
P/E Ratio	-0.35	-0.38
Forward P/E	N/A	17.33
Debt to Equity	176.75%	0.00%
Free Cash Flow Yield	N/A	-62.83%

Market Cap

Winner

MDCX

$18M

GTBP

$18M

Max Drawdown

Winner

MDCX

96.47%

GTBP

99.99%

Sharpe Ratio

Winner

MDCX

-0.69

GTBP

-0.73

5Y Beta

Winner

MDCX

1.00

GTBP

1.24

Industry

MDCX

Drug Manufacturers - General

GTBP

Biotechnology

P/E Ratio

MDCX

-0.35

Winner

GTBP

-0.38

Forward P/E

MDCX

N/A

GTBP

17.33

Debt to Equity

MDCX

176.75%

Winner

GTBP

0.00%

Free Cash Flow Yield

MDCX

N/A

GTBP

-62.83%

MDCX vs GTBP - Historical Returns

Returns include dividend reinvestment.

Period	MDCX	GTBP
1 month	+57.16%	+41.09%
3 months	-8.50%	+19.81%
6 months	-72.44%	-30.04%
1 year	-82.27%	-82.52%
5 years(CAGR)	+31.94%	-75.13%
10 years(CAGR)	+86.42%	-63.16%
Max(CAGR)	+86.84%	-63.16%

Winner

MDCX

+57.16%

GTBP

+41.09%

MDCX

-8.50%

Winner

GTBP

+19.81%

MDCX

-72.44%

Winner

GTBP

-30.04%

Winner

MDCX

-82.27%

GTBP

-82.52%

5Y(CAGR)

Winner

MDCX

+31.94%

GTBP

-75.13%

10Y(CAGR)

Winner

MDCX

+86.42%

GTBP

-63.16%

Max(CAGR)

Winner

MDCX

+86.84%

GTBP

-63.16%

MDCX vs GTBP - Annual Returns (2016 - 2026)

Returns include dividend reinvestment.

Year	MDCX	GTBP
2026	-71.41%	-37.09%
2025	-39.04%	-73.29%
2024	-8.30%	-60.13%
2023	N/A	-75.00%
2022	N/A	-72.24%
2021	N/A	-58.29%
2020	N/A	+328.28%
2019	N/A	-89.11%
2018	+205.73%	-85.06%
2017	+346.67%	-28.23%
2016	+114.29%	N/A

MDCX vs GTBP Drawdown Comparison

The maximum drawdown for MDCX was -96.47%, occurring on May 5, 2026. This drawdown has not yet recovered.

The maximum drawdown for GTBP was -99.99%, occurring on Apr 29, 2026. This drawdown has not yet recovered.

The current MDCX drawdown is -94.12%. The current GTBP drawdown is -99.99%.

Rank	MDCX	GTBP
#1	-96.47% May 19, 2025 - May 5, 2026	-99.99% Oct 20, 2017 - Apr 29, 2026
#2	-80.08% May 31, 2017 - Apr 19, 2018	-31.45% Sep 22, 2017 - Oct 17, 2017
#3	-78.35% Mar 7, 2017 - Apr 17, 2017	N/A
#4	-66.22% Feb 6, 2017 - Mar 6, 2017	N/A
#5	-63.33% Nov 4, 2016 - Feb 6, 2017	N/A
#6	-60.00% Feb 9, 2016 - Nov 4, 2016	N/A
#7	-49.90% Apr 20, 2018 - Nov 14, 2024	N/A
#8	-42.26% Feb 27, 2025 - May 9, 2025	N/A
#9	-37.60% Apr 17, 2017 - May 31, 2017	N/A
#10	-27.55% Nov 14, 2024 - Nov 29, 2024	N/A
#11	-22.74% Dec 6, 2024 - Feb 11, 2025	N/A
#12	-8.72% Nov 29, 2024 - Dec 3, 2024	N/A
#13	-5.93% Feb 20, 2025 - Feb 27, 2025	N/A
#14	-5.85% May 14, 2025 - May 16, 2025	N/A
#15	-3.11% Dec 3, 2024 - Dec 5, 2024	N/A

Correlation

Correlation between MDCX and GTBP is -0.62 which considered as a moderate negative correlation - the stocks show some tendency to move in opposite directions.

-0.62

-101